Lamiide structure
|
Common Name | Lamiide | ||
---|---|---|---|---|
CAS Number | 27856-54-8 | Molecular Weight | 422.381 | |
Density | 1.7±0.1 g/cm3 | Boiling Point | 667.2±55.0 °C at 760 mmHg | |
Molecular Formula | C17H26O12 | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | 237.8±25.0 °C |
Use of LamiideLamiide, an orally active iridoid compound, can be found in Bouchea fluminensis leaves. Lamiide exhibits anti-inflammatory and anti-lipoperoxidative activity[1]. |
Name | lamiide |
---|---|
Synonym | More Synonyms |
Description | Lamiide, an orally active iridoid compound, can be found in Bouchea fluminensis leaves. Lamiide exhibits anti-inflammatory and anti-lipoperoxidative activity[1]. |
---|---|
Related Catalog | |
In Vitro | Lamiide inhibits rat-brain phospholipid peroxidation, with an IC50 of 0.92 mM[1]. |
In Vivo | Lamiide (12.5-100 mg/kg; p.o. 30 min before Carrageenin injection) dose-dependently reduces Carrageenin-induced edema[1]. Animal Model: Female Wistar rats (8-weeks old, 150-200 g) were injected with Carrageenin in the subplantar aponeurosis of the right hind paw[1] Dosage: 12.5, 25, 50, 100 mg/kg Administration: P.o. 30 min before Carrageenin injection Result: Reduced Carrageenin-induced edema, with an ED50 of 62.3 mg/kg. |
References |
Density | 1.7±0.1 g/cm3 |
---|---|
Boiling Point | 667.2±55.0 °C at 760 mmHg |
Molecular Formula | C17H26O12 |
Molecular Weight | 422.381 |
Flash Point | 237.8±25.0 °C |
Exact Mass | 422.142426 |
PSA | 195.60000 |
LogP | -3.03 |
Vapour Pressure | 0.0±4.6 mmHg at 25°C |
Index of Refraction | 1.644 |
Storage condition | ?20°C |
RIDADR | NONH for all modes of transport |
---|
Methyl (1S,4aR,6S,7R,7aS)-1-(β-D-glucopyranosyloxy)-4a,6,7-trihydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylate |
Cyclopenta[c]pyran-4-carboxylic acid, 1-(β-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-4a,6,7-trihydroxy-7-methyl-, methyl ester, (1S,4aR,6S,7R,7aS)- |